Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Related Citations for PubMed (Select 12755662)

1.

Metabolic syndrome in patients with schizophrenia.

Heiskanen T, Niskanen L, Lyytikäinen R, Saarinen PI, Hintikka J.

J Clin Psychiatry. 2003 May;64(5):575-9.

PMID:
12755662
2.

A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study.

Saari KM, Lindeman SM, Viilo KM, Isohanni MK, Järvelin MR, Laurén LH, Savolainen MJ, Koponen HJ.

J Clin Psychiatry. 2005 May;66(5):559-63.

PMID:
15889940
3.

Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.

Suvisaari JM, Saarni SI, Perälä J, Suvisaari JV, Härkänen T, Lönnqvist J, Reunanen A.

J Clin Psychiatry. 2007 Jul;68(7):1045-55.

PMID:
17685741
4.

Prevalence of the metabolic syndrome among patients receiving clozapine.

Lamberti JS, Olson D, Crilly JF, Olivares T, Williams GC, Tu X, Tang W, Wiener K, Dvorin S, Dietz MB.

Am J Psychiatry. 2006 Jul;163(7):1273-6.

PMID:
16816234
6.
7.

Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan.

Huang MC, Lu ML, Tsai CJ, Chen PY, Chiu CC, Jian DL, Lin KM, Chen CH.

Acta Psychiatr Scand. 2009 Oct;120(4):274-80. doi: 10.1111/j.1600-0447.2009.01401.x. Epub 2009 May 7.

PMID:
19426161
8.

Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database.

Sicras-Mainar A, Blanca-Tamayo M, Rejas-Gutiérrez J, Navarro-Artieda R.

Eur Psychiatry. 2008 Mar;23(2):100-8. Epub 2007 Sep 29.

PMID:
17904825
9.

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.

De Hert MA, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J.

Schizophr Res. 2006 Mar;83(1):87-93. Epub 2006 Feb 14.

PMID:
16481149
10.

A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study.

Arango C, Bobes J, Aranda P, Carmena R, Garcia-Garcia M, Rejas J; CLAMORS Study Collaborative Group.

Schizophr Res. 2008 Sep;104(1-3):1-12. doi: 10.1016/j.schres.2008.05.009. Epub 2008 Jul 7.

PMID:
18606526
11.

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.

van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J.

Bipolar Disord. 2008 Mar;10(2):342-8. doi: 10.1111/j.1399-5618.2007.00520.x.

PMID:
18271914
12.

The prevalence of metabolic syndrome among psychiatric inpatients in Brazil.

Teixeira PJ, Rocha FL.

Rev Bras Psiquiatr. 2007 Dec;29(4):330-6.

13.

Visual impairment in persons with psychotic disorder.

Viertiö S, Laitinen A, Perälä J, Saarni SI, Koskinen S, Lönnqvist J, Suvisaari J.

Soc Psychiatry Psychiatr Epidemiol. 2007 Nov;42(11):902-8. Epub 2007 Sep 10.

PMID:
17846698
14.

Metabolic risk factors in drug-naive patients with first-episode psychosis.

Verma SK, Subramaniam M, Liew A, Poon LY.

J Clin Psychiatry. 2009 Jul;70(7):997-1000. doi: 10.4088/JCP.08m04508. Epub 2009 Jun 2.

PMID:
19497246
15.

Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey.

Suvisaari J, Perälä J, Saarni SI, Härkänen T, Pirkola S, Joukamaa M, Koskinen S, Lönnqvist J, Reunanen A.

Eur Arch Psychiatry Clin Neurosci. 2008 Apr;258(3):129-36.

PMID:
17990051
16.

High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia.

Hägg S, Lindblom Y, Mjörndal T, Adolfsson R.

Int Clin Psychopharmacol. 2006 Mar;21(2):93-8.

PMID:
16421460
17.

The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, Patel JK, Keefe RS, Stroup TS, Lieberman JA.

Schizophr Res. 2005 Dec 1;80(1):9-18. Epub 2005 Aug 24.

PMID:
16125372
18.

Prevalence of metabolic syndrome among inpatients with schizophrenia.

Boke O, Aker S, Sarisoy G, Saricicek EB, Sahin AR.

Int J Psychiatry Med. 2008;38(1):103-12.

PMID:
18624022
19.

Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study.

Arango C, Bobes J, Kirkpatrick B, Garcia-Garcia M, Rejas J.

Eur Neuropsychopharmacol. 2011 Dec;21(12):867-75. doi: 10.1016/j.euroneuro.2011.03.005. Epub 2011 Apr 7.

PMID:
21477998
20.

Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.

Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, Lanctôt G, Saindon J, Vincent A, Gagnon S, Tremblay A.

Aust N Z J Psychiatry. 2007 Dec;41(12):980-9.

PMID:
17999270
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk